Advances in pediatric psychooncology.

Lori Wiener, Katie A Devine, Amanda L Thompson
Author Information
  1. Lori Wiener: Pediatric Oncology Branch, National Cancer Institute, Center for Cancer Research, National Institutes of Health, Bethesda, Maryland.
  2. Katie A Devine: Rutgers Cancer Institute of New Jersey, Rutgers, The State University of New Jersey, New Brunswick, New Jersey.
  3. Amanda L Thompson: Center for Cancer and Blood Disorders, Children's National Hospital, Washington, DC, USA.

Abstract

PURPOSE OF REVIEW: This article reviews the current literature on psychosocial care of children with cancer with particular focus on evidence-based standards of care, including developments in systematic distress screening, utilization of patient-reported outcomes, evidence-based interventions, survivorship, palliative care and bereavement.
RECENT FINDINGS: Although attention to the psychosocial needs of the child and family is increasingly recognized as an essential element of care for children with cancer, implementing evidence-based care remains suboptimal. Recent efforts have focused on utilizing technology to improve the reach of these interventions and to enhance engagement with special populations, such as adolescents and young adults. Increasing data elucidate the long-term psychological and physical late effects of childhood cancer survivorship and the impact of cancer on siblings and the family. Gaps in clinical care and important directions for future research include the needs of infants and toddlers, overlooked minorities, and patients with hereditary tumor predisposition syndromes, and attention to the psychosocial impact of exciting new treatments, such as autologous chimeric antigen receptor (CAR) T-cell therapy.
SUMMARY: The evidence base for the psychosocial standards of care for children with cancer and their families continues to grow, but more work is needed to successfully implement these standards across pediatric cancer centers.

References

  1. Psychooncology. 2018 Apr;27(4):1244-1250 [PMID: 29405486]
  2. J Pediatr Psychol. 2019 Aug 1;44(7):774-776 [PMID: 31099849]
  3. Psychooncology. 2019 Jan;28(1):174-180 [PMID: 30353603]
  4. Nat Rev Clin Oncol. 2019 Jan;16(1):45-63 [PMID: 30082906]
  5. Palliat Support Care. 2018 Dec;16(6):706-711 [PMID: 29386073]
  6. Cancer. 2018 Oct 1;124(19):3934-3941 [PMID: 30216416]
  7. Psychooncology. 2018 Jun;27(6):1467-1479 [PMID: 29441699]
  8. Support Care Cancer. 2017 Jun;25(6):1759-1768 [PMID: 28105523]
  9. J Psychosoc Oncol Res Pract. 2019 Jul;1(1): [PMID: 33225301]
  10. Psychooncology. 2018 Apr;27(4):1350-1352 [PMID: 29405538]
  11. Pediatr Blood Cancer. 2018 Dec;65(12):e27429 [PMID: 30160072]
  12. Pediatr Blood Cancer. 2019 Feb;66(2):e27498 [PMID: 30318743]
  13. J Pediatr Psychol. 2018 Nov 1;43(10):1093-1103 [PMID: 29893947]
  14. Death Stud. 2021;45(4):313-321 [PMID: 31274055]
  15. Cell Death Dis. 2018 Feb 15;9(3):282 [PMID: 29449531]
  16. Psychooncology. 2018 Dec;27(12):2829-2839 [PMID: 30238545]
  17. Lancet. 2017 Dec 9;390(10112):2569-2582 [PMID: 28890157]
  18. J Pediatr Oncol Nurs. 2016 Sep;33(5):378-86 [PMID: 26668211]
  19. Psychooncology. 2019 Mar;28(3):577-585 [PMID: 30636177]
  20. Palliat Support Care. 2017 Feb;15(1):57-66 [PMID: 27516152]
  21. Pediatr Blood Cancer. 2019 Mar;66(3):e27526 [PMID: 30426667]
  22. Cancer. 2018 Oct 1;124(19):3909-3917 [PMID: 30230531]
  23. Psychooncology. 2019 Jan;28(1):198-200 [PMID: 30242937]
  24. J Pediatr Psychol. 2019 Aug 1;44(7):761-763 [PMID: 31131854]
  25. J Pediatr Psychol. 2018 Oct 1;43(9):1047-1058 [PMID: 29800307]
  26. Clin Pract Pediatr Psychol. 2019 Mar;7(1):44-56 [PMID: 38333421]
  27. J Adolesc Young Adult Oncol. 2018 Jun;7(3):259-262 [PMID: 29336661]
  28. Acta Oncol. 2015 May;54(5):574-80 [PMID: 25752970]
  29. Cancer. 2015 Dec 15;121(24):4416-24 [PMID: 26348790]
  30. Psychooncology. 2017 Apr;26(4):563-569 [PMID: 27530206]
  31. Psychooncology. 2018 Dec;27(12):2869-2872 [PMID: 30161277]
  32. Psychooncology. 2019 Mar;28(3):622-628 [PMID: 30664284]
  33. Pediatr Blood Cancer. 2019 May;66(5):e27606 [PMID: 30663254]
  34. Psychooncology. 2019 Apr;28(4):913-919 [PMID: 30812064]
  35. J Clin Oncol. 2013 Apr 1;31(10):1329-35 [PMID: 23358975]
  36. J Pediatr Psychol. 2019 Jul 1;44(6):669-678 [PMID: 30874803]
  37. Psychooncology. 2019 Jan;28(1):68-75 [PMID: 30402997]
  38. Pediatr Blood Cancer. 2019 Jan;66(1):e27445 [PMID: 30207072]
  39. J Pediatr Psychol. 2018 Aug 1;43(7):737-748 [PMID: 29509908]
  40. Pediatr Blood Cancer. 2018 Jan;65(1): [PMID: 28941160]
  41. J Pediatr Psychol. 2019 Aug 1;44(7):764-767 [PMID: 30990524]
  42. Psychooncology. 2017 Apr;26(4):461-468 [PMID: 26620722]
  43. Bone Marrow Transplant. 2019 Nov;54(11):1780-1788 [PMID: 30971776]
  44. J Pain Symptom Manage. 2014 Mar;47(3):594-603 [PMID: 23870843]
  45. J Pediatr Psychol. 2019 Jun 1;44(5):557-566 [PMID: 30624691]
  46. Pediatr Blood Cancer. 2015 Dec;62 Suppl 5:S419-24 [PMID: 26397836]
  47. Pediatr Blood Cancer. 2019 Aug;66(8):e27775 [PMID: 31038281]
  48. Support Care Cancer. 2017 Mar;25(3):769-774 [PMID: 27747479]
  49. Pediatrics. 2018 Nov;142(5): [PMID: 30341154]
  50. Pediatr Blood Cancer. 2018 Nov;65(11):e27356 [PMID: 30084222]
  51. Pediatr Blood Cancer. 2018 Sep;65(9):e27242 [PMID: 29893482]
  52. Palliat Support Care. 2019 Feb;17(1):2-12 [PMID: 30683164]
  53. Pediatr Blood Cancer. 2016 Dec;63(12):2181-2188 [PMID: 27511830]
  54. Psychooncology. 2019 Apr;28(4):903-912 [PMID: 30817058]
  55. J Pediatr Psychol. 2019 Mar 1;44(2):186-196 [PMID: 30247631]
  56. Pediatr Blood Cancer. 2015 Dec;62 Suppl 5:S632-83 [PMID: 26700921]
  57. Pediatr Blood Cancer. 2019 Mar;66(3):e27530 [PMID: 30426663]
  58. J Cancer Surviv. 2019 Aug;13(4):580-592 [PMID: 31350681]
  59. Psychooncology. 2015 Feb;24(2):204-11 [PMID: 24906202]
  60. Pediatr Blood Cancer. 2012 Mar;58(3):435-40 [PMID: 21755591]
  61. Support Care Cancer. 2020 Apr;28(4):1631-1638 [PMID: 31280364]
  62. Clin Pract Pediatr Psychol. 2019;7(1):31-43 [PMID: 38882593]
  63. Pediatr Blood Cancer. 2016 Jan;63(1):105-11 [PMID: 26398865]
  64. Pediatr Blood Cancer. 2015 Dec;62 Suppl 5:S619-31 [PMID: 26700920]
  65. J Adolesc Young Adult Oncol. 2019 Oct;8(5):525-528 [PMID: 31199707]
  66. J Clin Psychol Med Settings. 2020 Mar;27(1):41-47 [PMID: 30993575]
  67. BMJ Paediatr Open. 2019 Jan 31;3(1):e000417 [PMID: 30815590]
  68. Pediatr Blood Cancer. 2019 Jul;66(7):e27728 [PMID: 30916456]
  69. Psychooncology. 2017 Dec;26(12):2109-2117 [PMID: 27859953]
  70. Pediatr Blood Cancer. 2019 Jan;66(1):e27438 [PMID: 30239111]
  71. Psychooncology. 2019 Jan;28(1):92-98 [PMID: 30315686]
  72. Pediatr Blood Cancer. 2018 Mar;65(3): [PMID: 29080381]
  73. Psychooncology. 2018 Aug;27(8):1979-1986 [PMID: 29740904]
  74. Psychooncology. 2019 Feb;28(2):284-292 [PMID: 30414219]
  75. Pediatr Blood Cancer. 2018 Dec;65(12):e27380 [PMID: 30069999]
  76. Psychooncology. 2011 Dec;20(12):1324-33 [PMID: 20925136]
  77. Pediatrics. 2016 Dec;138(6): [PMID: 27940700]

Grants

  1. Z99 CA999999/Intramural NIH HHS

MeSH Term

Adolescent
Cancer Survivors
Child
Child, Preschool
Family
Humans
Immunotherapy, Adoptive
Infant
Neoplasms
Palliative Care
Psycho-Oncology
Siblings
Young Adult

Word Cloud

Created with Highcharts 10.0.0carecancerpsychosocialchildrenevidence-basedstandardsinterventionssurvivorshipattentionneedsfamilyimpactpediatricPURPOSEOFREVIEW:articlereviewscurrentliteratureparticularfocusincludingdevelopmentssystematicdistressscreeningutilizationpatient-reportedoutcomespalliativebereavementRECENTFINDINGS:AlthoughchildincreasinglyrecognizedessentialelementimplementingremainssuboptimalRecenteffortsfocusedutilizingtechnologyimprovereachenhanceengagementspecialpopulationsadolescentsyoungadultsIncreasingdataelucidatelong-termpsychologicalphysicallateeffectschildhoodsiblingsGapsclinicalimportantdirectionsfutureresearchincludeinfantstoddlersoverlookedminoritiespatientshereditarytumorpredispositionsyndromesexcitingnewtreatmentsautologouschimericantigenreceptorCART-celltherapySUMMARY:evidencebasefamiliescontinuesgrowworkneededsuccessfullyimplementacrosscentersAdvancespsychooncology

Similar Articles

Cited By (2)